Hendrik Peter Scholl
CIK 2113223 · Chief Medical Officer · last filed 2026-10-05
Hendrik Peter Scholl is a Chief Medical Officer who has filed 7 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing shows the insider sold $82.7K of BLTE on Oct 5, 2026. Across all open-market trades the lifetime net is −$2.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions. 3 Form 144 notices of planned sales are also on file; the latest, for Belite Bio, Inc. on Oct 1, 2026, lists the filer as an officer. 1 sale listed on those notices, worth $1.4M in all, has no matching Form 4.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLTE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ZUG 6300
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLTE | Chief Medical Officer | 14,500 | $152.72 | $2.21M | -$2.94M | 4 | 2026-10-05 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| BLTE | By Bioptima Ltd. | 14,500 | 100.0% | 2026-10-05 |
| Total | 14,500 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-05 | BLTE | Sell (S)10b5-1 Plan adopted Jun 25, 2026 |
−500 | -$82.7K | EDGAR |
| 2026-10-01 | Belite Bio, Inc. | Notice (144) Officer · Planned Oct 1, 2026 · 10b5-1 plan No sale on file |
−4,000 | -$679.3K | EDGAR |
| 2026-06-22 | BLTE | Sell (S) | −10,000 | -$1.45M | EDGAR |
| 2026-06-18 | Belite Bio, Inc. | Notice (144) Affiliate · Seller: Dr. Hendrick P. Scholl · Planned Jun 18, 2026 No sale on file |
−10,000 | -$1.48M | EDGAR |
| 2026-06-17 | BLTE | Sell (S) | −10,000 | -$1.41M | EDGAR |
| 2026-06-16 | Belite Bio, Inc. | Notice (144) Affiliate · Seller: Dr. Hendrick P. Scholl · Planned Jun 16, 2026 Sold: listed on the Jun 18, 2026 notice |
−10,000 | -$1.44M | EDGAR |
| 2026-04-23 | BLTE | Other (J) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
1 sale · $1.44M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2026-06-16 | Belite Bio, Inc. Seller: Dr. Hendrick P. Scholl |
10,000 | $1.44M | $144.24 | 2026-06-18 |